Print
A New Risk Measurement Tool for Those at High Risk for Ovarian Cancer
https://www.facingourrisk.org/research-clinical-trials/study/236/a-new-risk-measurement-tool-for-those-at-high-risk-for-ovarian-cancer
Clinicaltrials.gov identifier:
NCT04487405 (https://clinicaltrials.gov/show/NCT04487405)
Prevention
This study is using a new type of genetic test to measure ovarian cancer risk
Study Contact Information:
Contact: Tatiana Ferreira-Black by phone: 512-800-2885 or by email
About the Study
This study is using a new type of genetic test to measure ovarian cancer risk in women who have inherited gene mutations that increase their risk for ovarian cancer or women who have an ovarian cyst or a growth in the area of the ovaries or fallopian tubes (adnexal mass). This genetic test looks at seven genetic markers and then provides a score on a scale from 0 to 20 that will tell you your risk for ovarian cancer. The higher the score, the higher your risk.
What the Study Involves
There are three groups that this study is recruiting. Each group will undergo a blood draw to use the risk measurement tool (OVAnex) so that each participant will have a risk score on a scale from 0 to 20.
- Group A is for women with an ovarian cyst or other benign ovarian who have symptoms from the mass
- Group B is for women who have an ovarian cyst or other benign mass who have no symptoms from the mass
- Group C is for women with an inherited gene mutation that puts them at high risk for ovarian cancer
Participants will be enrolled in the study for a total of 12 months.
Study Locations
Arizona
- Chandler
Women's Health Arizona
Contact: Dr. Monte Swarup by email
Georgia
- Columbus
MidTown OBGYN
Contact: Dr. Serena Tidwell by email
Contact: Rebecca Watkins by email
Minnesota
- Eden Prairie
Premier OBGYN of Minnesota
Contact: Dr. Katie Toft by email
New York
- New Hyde Park
Square Care Health
Contact: Dr. Frank Dolisi by email
Ohio
- Cincinnati
Seven Hills Clinical Research Group
Contact: Gerard Reilly, MD by email
Pennsylvania
- Lancaster
May Grant OB/GYN
Contact: Dr. Kent Meldrum by email
Texas
- Austin
Hill Country OBGYN Associates
Contact: Dr. Ana Eduardo by email
This Study is Open To:
- Women over the age of 18 with an ovarian cyst or other mass that isn't cancer, or in follow-up due to the presence of an inherited mutation in BRCA1, BRCA2 or other gene linked to ovarian cancer risk.
- The patient reviewed, understood, and provided the study team with written informed consent to allow blood specimen to be used for research and release of medical information.
*Contact your doctor, the study coordinators or review the clinicaltrials.gov listing for a complete list of inclusion criteria.
This Study is Not Open To:
- Participant is less than 18 years of age
- Participant is not being treated in the U.S.
*Contact your doctor, the study coordinators or review the clinicaltrials.gov listing for a complete list of inclusion criteria.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.